Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Paul F, Mathew"'
Autor:
Prem P. Batchala, Paul F. Mathew, Linda W. Martin, Baphiralyne Wankhar, Vijayanadh Ojili, Pankaj Nepal, James T. Patrie
Publikováno v:
Clinical Imaging. 91:97-104
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::16bd0beaac89811d85d40b1db0ec2f2b
https://doi.org/10.1016/j.clinimag.2022.08.016
https://doi.org/10.1016/j.clinimag.2022.08.016
Autor:
Christopher J. Logothetis, Lorenzo Cohen, Nizar M. Tannir, Arlene O. Siefker-Radtke, Xuemei Wang, Chaan S. Ng, Paul F. Mathew, Peter F. Thall, Eric Jonasch, Lance C. Pagliaro
Publikováno v:
Cancer. 107:2254-2261
BACKGROUND. In vivo data have shown a more potent antiangiogenic effect and a higher antitumor activity of low-dose interferon (IFN) given twice daily. In a randomized Phase II trial, the authors tested the hypothesis that twice-daily low-dose IFN is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::801eb7a8bab0a390db92c176697dd7f5
https://doi.org/10.1002/cncr.22253
https://doi.org/10.1002/cncr.22253
Autor:
Louis L. Pisters, Eleni Efstathiou, Kim Anh Do, Rita F. Tibbs, Neil A. Abrahams, Curtis A. Pettaway, Xuemei Wang, Christopher J. Logothetis, Paul F. Mathew, Patricia Troncoso
Publikováno v:
European urology. 57(6)
Preoperative treatment of prostate cancer (PCa) changes morphology of residual tumors so that the Gleason score is no longer valid.To codify morphologic features of preoperatively treated PCa and identify potential classifiers predictive of outcome.W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bcc3de205030b399c3738e1489cc7d2
https://pubmed.ncbi.nlm.nih.gov/19853370
https://pubmed.ncbi.nlm.nih.gov/19853370
Autor:
Tannir, Nizar M., Cohen, Lorenzo, Wang, Xuemei, Thall, Peter, Mathew, Paul F., Jonasch, Eric, Siefker-Radtke, Arlene, Pagliaro, Lance C., Ng, Chaan S., Logothetis, Christopher
Publikováno v:
Cancer (0008543X); Nov2006, Vol. 107 Issue 9, p2254-2261, 8p